Search Results

You are looking at 91 - 93 of 93 items for :

  • "dose intensity" x
Clear All
Full access

William J. Gradishar, Benjamin O. Anderson, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, Daniel F. Hayes, Clifford A. Hudis, Steven J. Isakoff, Britt-Marie E. Ljung, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Robert S. Miller, Mark Pegram, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Mary Lou Smith, Hatem Soliman, George Somlo, John H. Ward, Antonio C. Wolff, Richard Zellars, Dorothy A. Shead and Rashmi Kumar

. Polychemotherapy for early breast cancer: an overview of the randomised trials . Early Breast Cancer Trialists’ Collaborative Group . Lancet 1998 ; 352 : 930 – 942 . 259. Wood WC Budman DR Korzun AH . Dose and dose intensity of adjuvant chemotherapy

Full access

high adverse events (AE) rates. Our goal was to prove the safety and efficacy of a higher dose intensity biweekly FM schedule. Methods: This is a phase I-II trial on FM in patients affected by histology-determined r GBM with unmethylated MGMT

Full access

Robert W. Carlson, D. Craig Allred, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, John K. Erban, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Britt-Marie Ljung, David A. Mankoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lori J. Pierce, Elizabeth C. Reed, Jasgit Sachdev, Mary Lou Smith, George Somlo, John H. Ward, Antonio C. Wolff and Richard Zellars

– 942 . 210. Wood WC Budman DR Korzun AH . Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma . N Engl J Med 1994 ; 330 : 1253 – 1259 . 211. Menard S Valagussa P Pilotti S . Response to